Stockreport

Travere Therapeutics Announces Pricing of Public Offering of Common Stock

Travere Therapeutics, Inc.  (TVTX) 
PDF SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced the pricing of an underwritten public offering of 7,812,500 shar [Read more]